Drug-labels.com

Mint-Acyclovir: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
200 mg, 400 mg, 800 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Mint-Acyclovir

ABOUT THIS MEDICATION

What the medication is used for and what it does:

MINT-ACYCLOVIR (Acyclovir Tablets USP) is an antiviral medicine.

Treatment of Shingles (Herpes Zoster)

MINT-ACYCLOVIR is used to treat shingles (herpes zoster) infections. Shingles is caused by the varicella- zoster virus. The virus multiplies in and eventually destroys affected skin cells. MINT-ACYCLOVIR stops the virus from multiplying and therefore from spreading to neighbouring healthy cells. It cannot replace a cell which has been damaged by the multiplying virus, but it will facilitate the process of healing.

Treatment and Suppression of Genital Herpes

MINT-ACYCLOVIR is used to treat initial episodes of genital herpes.

Genital herpes is a sexually transmitted infection caused by the herpes simplex virus (HSV). HSV causes small, fluid-filled blisters in the genital area which break down into ulcers/sores which may be itchy or painful. The fluid in these blisters contains the virus which causes the disease. It is a feature of all herpes viruses that once in the body, they stay there throughout life alternating between active (outbreak) and inactive states.

When taken on a daily basis, MINT-ACYCLOVIR can also be used to prevent the HSV infection from coming back. This type of treatment is called suppressive therapy.

When it should not be used:

You should not use MINT-ACYCLOVIR if you are allergic to or react badly to acyclovir or valacyclovir or any other components of the formulation of MINT- ACYCLOVIR (see "What the non-medicinal ingredients are" section). Tell your doctor if you have ever had an allergic reaction to any of these ingredients.

What the medicinal ingredient is:

MINT-ACYCLOVIR Tablets contain the active ingredient acyclovir.

What the important non-medicinal ingredients are:

MINT-ACYCLOVIR 200 mg Tablets contain the non- medicinal ingredients colloidal silicon dioxide, FD&C Blue #2 indigo carmine AL 30% - 36%, magnesium stearate, microcrystalline cellulose, povidone, and sodium starch glycolate.

MINT-ACYCLOVIR 400 mg Tablets contain the non- medicinal ingredients colloidal silicon dioxide, ferric oxide (sicovit red 30E 172), magnesium stearate, microcrystalline cellulose, povidone, and sodium starch glycolate.

MINT-ACYCLOVIR 800 mg Tablets contain the non- medicinal ingredients colloidal silicon dioxide, FD&C Blue #2 indigo carmine AL 30% - 36%, magnesium stearate, microcrystalline cellulose, povidone, and sodium starch glycolate.

What dosage forms it comes in:

MINT-ACYCLOVIR is available in tablets containing 200 mg, 400 mg or 800 mg of acyclovir.

WARNINGS AND PRECAUTIONS

Before using MINT-ACYCLOVIR (Acyclovir Tablets USP), tell your doctor if:

  • You have kidney problems or if you are 65 years of age or older. Your doctor may give you a lower dose of MINT-ACYCLOVIR and/or ask you to stay hydrated.
  • You are severely immunocompromised (e.g. suffering a severe disease or have recently undergone an organ transplant and are taking immunosuppressant drugs for either of these conditions).
  • You are pregnant, planning to become pregnant, breastfeeding or planning to breastfeed.

The safety and effectiveness in children less than 2 years of age are not known.

You must make sure you drink plenty of liquids such as water while you are being given MINT-ACYCLOVIR.

Feeling drowsy or sleepy may impair your ability to concentrate and react. Make sure you are not affected before you drive or operate machinery.

When using MINT-ACYCLOVIR for suppression of genital herpes, your doctor may periodically stop your drug therapy in order to reassess your need for continuous treatment. The effect of long-term use in humans has not been fully assessed. Prudence is therefore suggested when choosing continuous, long term therapy with MINT-ACYCLOVIR. Suppression of recurrent genital herpes is therefore, only recommended in those who are severely affected. Some patients experience increased severity of the first episode of genital herpes after stopping treatment.

Genital herpes is passed from one person to another through direct intimate contact. To reduce the risk of transmission, wash your hands immediately if you touch your skin sores, and do not touch other parts of your body until you have done so. Especially avoid intimate contact with others when the disease is visible. Herpes virus particles may also be released when you do not have blisters or sores. For this reason, it is safest to believe that you can spread the infection to your partner even when sores are not present.

Although decreased sperm counts were observed in animals treated with high doses, these effects did not occur in humans.

PROPER USE OF THIS MEDICATION

Medication should not be shared with others. The prescribed dosage should not be exceeded. Tablets should be swallowed whole, with water.

Usual dose for shingles:

For the treatment of shingles (herpes zoster), the usual dose of MINT-ACYCLOVIR (Acyclovir Tablets USP) is 800 mg every 4 hours, 5 times daily for 7 to 10 days. MINT-ACYCLOVIR must be taken as early as possible within 72 hours of the onset of lesions.

Usual dose for genital herpes:

For the treatment of an initial episode of genital herpes, the usual dose of MINT-ACYCLOVIR is 200 mg every 4 hours, 5 times daily (maximum 1 g daily) for 10 days. MINT-ACYCLOVIR must be taken as early as possible following onset of signs and symptoms.

For the suppression of genital herpes, the usual dose of MINT-ACYCLOVIR is 200 mg 3 to 5 times daily or 400 mg twice daily. You should follow dosing instructions carefully. The objective is to keep enough of the drug in the body at all times to prevent the herpes virus from multiplying. Your doctor will try to prescribe the minimum dose required to do this in your case and may therefore increase or decrease your dose during the first few weeks. Follow your doctor's instruction carefully to ensure that you get the best possible response to treatment.

For the treatment of recurrent episodes of genital herpes, the usual dose of MINT-ACYCLOVIR is 200 mg every 4 hours 5 times daily for 5 days. MINT- ACYCLOVIR must be taken at the earliest sign or symptom (prodrome) of recurrence.

Overdose:

If you think you or a person you are caring for, have taken too much MINT-ACYCLOVIR, contact your healthcare professional, hospital emergency department, or regional poison control centre immediately, even if there are no symptoms.

Missed dose:

If you forget to take a dose, take it as soon as you remember. Then continue with the next dose at the proper time interval. Do not double doses.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

As with any widely prescribed medication, adverse events in association with the use of MINT- ACYCLOVIR (Acyclovir Tablets USP) are reported from time to time.

Common side effects may affect 1 to 10 people:

  • Headache,
  • Nausea, diarrhea, upset stomach vomiting
  • Feeling unwell
  • Weakness, lack of energy
  • Skin tingling, itching

Other side effects include: dizziness; high temperature (fever);itchy, bumpy rash; skin reaction after exposure to light (photosensitivity); hair loss; unusual bruising or bleeding; shortness of breath; effects on blood and urine tests; swelling of the face, lips, mouth, tongue or throat; increases in the enzymes that work in the liver; feeling agitated or confused; feeling shaky, unsteady and a lack of co-ordination; difficulty speaking or hoarseness; seeing or hearing things that are not really there; feeling drowsy or sleepy; inability to think or judge clearly or concentrate; disturbances of behaviour, speech and eye movements; unconsciousness; yellowing of the skin and whites of the eyes, inflammation of the liver; and changes to blood test results (reduced numbers of red blood cells, white blood cells, or blood platelets).

SERIOUS SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Symptom/ EffectTalk with your doctor or pharmacistStop taking drug and call your doctor or pharmacist
Only if severeIn all cases
UnknownSevere allergic reaction: itchy, bumpy rash; swelling, sometimes of the face or mouth causing difficulty in breathing; collapse√
Kidney failure: pain in the side (between ribs and hip) or kidney area of your back√
Blood disorders: unusual bruising or bleeding√

This is not a complete list of side effects. For any unexpected effects while taking MINT-ACYCLOVIR, contact your doctor or pharmacist.

HOW TO STORE IT

Store MINT-ACYCLOVIR (Acyclovir Tablets USP) Tablets at controlled room temperature (15° to 30°C). MINT- ACYCLOVIR Tablets should be stored in a dry place and protected from light and moisture. Preserve in tight containers.

Keep your MINT-ACYCLOVIR Tablets in a safe place where children cannot reach them or see them.

REPORTING SIDE EFFECTS

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect -canada/adverse-reaction-reporting.html)

    for information on how to report online, by mail or by fax; or

  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

If you want more information about MINT-ACYCLOVIR:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this Consumer Information by visiting the Health Canada website: (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html);

    The manufacturer’s website (www.mintpharmaceuticals.com) or by calling 1-877-398-9696.

Last revised: January 21, 2022

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02524708

Revision date stated in the text: January 21, 2022

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Mint-Acyclovir

Rx or OTC
Prescription (Rx)?
DIN 02524708, 02524716, 02524724
Schedule(s) PRESCRIPTION
Active ingredient(s) Acyclovir
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. J Antiinfectives for systemic use
    1. J05 Antivirals for systemic use
      1. J05A Direct acting antivirals
        1. J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors
          1. J05AB01 Acyclovir
Company MINT PHARMACEUTICALS INC
Current status Marketed
Current status date July 15, 2022
Strengths and forms
DIN Strength Dosage form(s) Current status
02524708 200 MG Tablet Marketed July 15, 2022
02524716 400 MG Tablet Marketed July 15, 2022
02524724 800 MG Tablet Marketed July 15, 2022

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.